Infinity Holdings Sidecar I and Infinity Holdings, managed by Infinity Investment Management, Investment Arm made an offer to acquire 26% stake in Jagsonpal Pharmaceuticals Limited (NSEI:JAGSNPHARM) for INR 1.6 billion on February 21, 2022. In the related transaction Infinity Investment Management entered into an agreement to acquire 43.7% stake in Jagsonpal Pharmaceuticals Limited. As per the article on March 4, 2022, Tendering Period April 13, 2022 and it will expire on April 28, 2022.

The transaction is expected to close on June 20, 2022. The Open Offer is not conditional upon any minimum level of acceptance. This Open Offer is subject to the terms and conditions mentioned in this Public Announcement.

The offer is subject to requisite approvals including approvals from RBI, statutory and other. Pooja Sanghvi and Priyanka Rijhwani of Centrum Capital Limited acted as the manager to Infinity Investment Management. Link Intime India Pvt.

Ltd. acted as registrar to Infinity Investment Management. Jefferies acted as financial advisor to Jagsonpal on the transaction. Khaitan & Co.

acted as legal advisor to Jagsonpal Pharmaceuticals Limited in the transaction.